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Original Article
Mycoplasma genitalium Infection Prevalence in Patients with Human 
Immunodeficiency Virus
Abstract  Objective: To determine the prevalence of Mycoplasma genitalium (M. 
genitalium) infection in HIV positive patients by PCR examination in Teratai 
Clinic of Dr. Hasan Sadikin General Hospital, Bandung in order to reduce sexually 
transmitted diseases, especially M. genitalium infection in HIV positive patients.
 Methods: This study was a cross-sectional study with consecutive sampling 
methods. Eighty one HIV positive patients attending the Teratai Clinic of Dr. 
Hasan Sadikin General Hospital, Bandung were recruited to be the subjects of 
this study. All subjects underwent history taking, physical examination, and PCR 
examination for M. genitalium. Specimens were taken from cervical smear in 
females and first void urine in male.
 Results: The prevalence of M. genitalium based on the PCR examination in HIV 
positive patients attended to Teratai Clinic Dr. Hasan Sadikin General Hospital 
Bandung was 9%. 
 Conclusions: Mycoplasmal infection identification based on PCR examination 
should be considered for routine screening test to reduce the incidence of 
sexually transmitted diseases in HIV positive patients.
 Keywords: Human immunodeficiency virus, Mycoplama genitalium, polymerase 
chain reaction
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Introduction
Mycoplama genitalium (M. genitalium) is the 
smallest bacterium, with a genome size of 580 
kb, of the Mollicutes Class (Mollis:soft, Cutis:skin, 
in Latin) that is mainly found in human genital 
tract.1,2 Several studies have already shown that 
M. genitalium is a sexually transmitted organism 
that causes asymptomatic or non-gonococcal 
urethritis (NGU) in males as well as cervicitis, 
endometritis, pelvic inflammatory disease in 
females.3-7
Mycoplama genitalium infection can be 
detected through culture, serological, and 
polymerase chain reaction (PCR) examinations. 
The culture examination may take several 
weeks or even months to grow M. genitalium. 
Hence, it cannot be used as a routine diagnostic 
tool in every day practice. In the serological 
examination, cross reactions may occur between 
M. genitalium and M. pneumoniae due to 
some similar structures, thereby decreasing the 
specificity of the test. The PCR examination can 
detect the microorganism in samples collected 
from the reproductive tracts in a highly sensitive, 
accurate, and specific manner. This leads to a 
situation where PCR is the only reliable diagnostic 
tool for M. genitalium infection.8 Currently, 
the PCR examination to detect M. genitalium 
is available for research only and not available 
comercially.9
Cross-sectional studies have shown a strong 
association between M. genitalium and HIV.10 
M. genitalium may play an important role in  the 
acquisition and transmission of HIV as also in 
other sexually transmitted diseases. Several in 
vitro studies have shown that the inflammatory 
response and mucosal disruption associated 
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with M. genitalium infection will increase  either 
the susceptibility or transmissibility, or both, to 
HIV infection.11
Research regarding the relationship between 
M. genitalium and HIV will provide knowledge 
on HIV cofactors that can be intervened. Studies 
among HIV positive patients in several clinics in 
Italy, Brazil, United States, and India have found 
that the prevalence rates of M. genitalium vary 
between 1% and 10%.10,12–15 There is no data on 
the prevalence M. genitalium in HIV positive 
patients in Indonesia, especially in West Java. 
The examination and treatment of M. genitalium 
infection in high-risk populations should be 
investigated as a potential strategy to prevent 
HIV.11 Therefore, a descriptive study was done 
to determine M. genitalium prevalence in HIV 
positive patients who visited Teratai Clinic of 
Dr. Hasan Sadikin General Hospital, Bandung 
through the use of PCR.
Methods
This study was an observational study with 
cross sectional design. The subjects were 81 
Table 1 Distribution of All Participant Based on PCR Result
Variable
PCR M. genitalium Total
Positive Negative n (%)
Sex
    Male 4 44 48 (59)
    Female 3 30 33 (41)
    Total (male+female) 7 74 81 (100)
Education 
    No education 0 0 0 (0)
    Elementary school 0 4 4 (5)
    Junior high school 1 3 4 (5)
    Senior high school 3 38 41 (51)
    College/University 3 29 32 (39)
Occupation
    Entrepreneur 3 32 35 (43)
    Employee 0 21 21 (26)
    Commercial sex worker 0 1 1 (1)
    Student 1 0 1 (1)
    Not working 3 20 23 (29)
Marital status 
    Single 3 15 18 (22)
    Married 3 42 45 (56)
    Widowers/widows 1 17 18 (22)
HIV positive patients who visited Teratai Clinic 
of Dr. Hasan Sadikin General Hospital Bandung 
who were taken in consecutive admission in July 
2012. The HIV serostatus of the study population 
had already been determined and confirmed 
based on National HIV guideline in Teratai Clinic 
before this study. The inclusion criteria for this 
study were male and female HIV patients in 
Teratai clinic who were sexually active. Female 
patients who were having her menstrual period 
were excluded from this study.
The study design was approved by the 
Research Ethics Committee of Health, Dr. Hasan 
Sadikin General Hospital, Bandung. The subjects 
were given a description on the research and if 
they were willing to participate in the study, they 
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Table 2 Sexual Behavior of Participants Based on PCR Result 
Variable
PCR M. genitalium Total
Positive Negative n (%)
Sexual orientation
     Heterosexual 6 66 72 (89)
     Homosexual 1 4 5 (6)
     Bisexual 0 4 4 (5)
Sexual practises
     Genital-genital (GG) 5      32 37 (46)
     GG+Oral-genital (OG) 1      31 32 (39)
     OG+Anal-genital (AG) 0       4 4 (5)
     GG+OG+AG 1       5 6 (7)
     GG+OG+AG+Oral-anal (OA) 0       2 2 (3)
Number of sexual partner in the last month
     0 person 4 23 27 (33)
     1 person 3 45 48 (59)
     ≥2 persons 0 6 6 (8)
Number of sexual partner in the last 3 months
     0 person 2 18 20 (25)
     1 person 5 41 46 (57)
     ≥2 persons 0 15 15 (18)
Number of lifetime sexual partner 
     1 person 2 19 21 (26)
     2–5 persons 5 34 39 (48)
     ≥6 persons 0 21 21 (26)
Condom use 
     Never 2 18 20 (25)
     Seldom 2 19 21 (26)
     Always 3 37 40 (49)
STI history
     Positive 5 38 43 (53)
     Negative 2 36 38 (47)
were asked to sign the informed consent. The 
subjects then underwent history taking, physical 
examination, and samples for PCR examination 
were collected from the first void urine in males 
and cervical swab in females.
The results were presented descriptively to 
determine the prevalence of M. genitalium based 
on PCR examination in HIV positive patients. The 
study was conducted at Teratai Clinic of Dr. Hasan 
Sadikin General Hospital, Bandung and the PCR 
examination for M. genitalium was performed at 
the Laboratory of Molecular Biology Department 
of Microbiology/Health Research Unit of the 
Faculty of Medicine, Universitas Padjadjaran, 
Bandung.
Thirty to fifty mL first void urine samples were 
collected from male patients in sterile specimen 
collection manner after the patient had not 
urinated for 2 hours. The cervical swabs for 
female patients were collected using a specimen 
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collection kit (Roche Ltd., Basel, Switzerland) 
and they were transported to the laboratory 
in transport medium tubes (Roche Ltd., Basel, 
Switzerland). Both specimens were transported 
to the laboratory on the day of collection. The 
DNAs from urine were isolated using Qiamp DNA 
extraction kit and the DNAs from cervical smears 
were isolated using Roche preparation kit. PCR 
for M. genitalium was performed using the PCR 
kit from Genekam Biotechnology AG. The PCR 
results were interpreted with agarose gel using 
a UV chamber. Positive results were established 
in accordance with the positive control bands 
(341bp) and no band on the negative control. 
The data were then stored in a file.
The data were recorded in the prepared 
research form, then the editing, verification, 
coding, and data entry were conducted using SPSS 
17.0. After that, the collected data were calculated 
for the percentage of M. genitalium positive PCR 
results. Data on subject characteristics and sexual 
behaviors were also  presented descriptively.
Results 
A total of 81 HIV positive patients were examined 
as a part of this cross-sectional study in order 
to determine the M. genitalium status. The 
prevalence of M. genitalium infection was 7/81. 
M. genitalium positive result for female was 
3/33 and 4/48 males were positive.
Discussion 
Culture examination may take several weeks 
or even months to grow M. genitalium, which 
makes it impossible to use it for diagnostic 
purpose in clinical practice. In serological 
testing, M. genitalium may have cross-reactivity 
with M. pneumoniae due to the similarity in 
structure, thereby decreasing the specificity of 
the serological tests. Currently, examination by 
PCR is the method of choice for the detection 
of M. genitalium and the most published target 
genes are major adhesin MgPa genes or 16S rRNA 
gene.1,9,16 The most sensitive clinical samples 
for testing M. genitalium in females when PCR 
is used, according to the study performed by 
Wroblewski et al.,17 is from the vaginal swab 
(91%) compared to the cervical smear (53%) 
and urine (65%). However, the vaginal smear 
examination has not been approved by the 
Food and Drug Administration. Jensen et al. in 
Shipitsyna et al.8 found that the first void urine in 
males can detect higher M. genitalium infections 
(98%) than urethral swabs (82%). 
To our knowledge, this is the first prevalence 
study of M. genitalium infection among HIV 
positive patients in Indonesia, especially in West 
Java. In this study, the M. genitalium infection 
prevalence in HIV positive patients in Teratai 
Clinic of Dr. Hasan Sadikin General Hospital, 
Bandung was 7/81. The M. genitalium positive 
results for female were found in 3/33 of the 
subjects and 4/48 were found in males. The 
results of this study were not much different 
from previous studies. Research conducted by 
da Costa et al.13 in 2009 in 223 males with HIV-1 
who visited the HIV Clinic in Sao Paulo General 
Hospital has obtained similar results, with the 
M. genitalium infection was found in 13 (6%) 
urine samples. Manhas et al.14 conducted a study 
on urine samples of 100 males patients who 
visited the NGU HIV and STI clinic in Chandigarh 
India in 2010, i.e. 70 HIV-positive cases and 30 
HIV-negative cases. In their study, M. genitalium 
infection was higher in HIV positive patients 
(7%), whereas in HIV negative patients, the 
infections was only 3%. However, the results 
showed no statistically significant difference in 
the frequency of M. genitalium infection in HIV 
positive and HIV negative patients.14
Gatski et al.10 in 2011 revealed that the 
prevalence of M. genitalium was 10% in HIV 
positive females in an HIV Clinic in New Orleans, 
the United States, with  samples taken from the 
cervix. In the study by Martinelli et al.12 it was 
found that the prevalence of M. genitalium was 
significantly higher statistically in males with 
AIDS (56%) compared to HIV positive patients 
(10%) and the normal population (7%). This 
may happen for two reasons: first, defects in 
humoral and cellular immunity in patients with 
AIDS, making them more prone to infection; 
second, the colonization of M. genitalium in 
urethral tract of AIDS patients that was resistant 
to antibiotics due to the use of broad-spectrum 
antibiotic prophylaxis in those patients.12
This study shows that the average age of 
patients with PCR M. genitalium positive was 
32 years old, with the youngest of 26 years 
old, and the oldest was 36 years old. These 
results suggested that M. genitalium infections 
generally occur during sexually active ages. It 
was found by da Costa et al.13 that the average 
age of subjects with positive M. genitalium in 
HIV positive males was 43 years old. Gatski et 
al.10 revealed that the average age of the HIV 
positive females subjects who were positive for 
M. genitalium was less than 35 years old, which 
were the sexually active population. Another 
study conducted by Anagrius et al.16 found that 
of 946 patients attending an STI clinic in Sweden 
the median age  of M. genitalium infection was 
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to high school graduates (72%). Pe’pin et al.20 
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university graduates.21
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for the group with positive M. genitalium result 
was 21.3 years. In the group with positive 
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the effectiveness of condom.25
    In summary, the prevalence of M. genitalium 
infection in HIV positive patients based on PCR 
examination in Teratai Clinic of Dr. Hasan Sadikin 
General Hospital, Bandung was 9%. Even though 
the prevalence of M. genitalium infection in HIV 
positive patients is low in this study, identifying 
mycoplasma infection based on PCR examination 
should be considered for routine screening test 
to reduce the incidence of sexually transmitted 
diseases in HIV positive patients.
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